|
1
|
Kumariya S, Ubba V, Jha RK and Gayen JR:
Autophagy in ovary and polycystic ovary syndrome: Role, dispute and
future perspective. Autophagy. 17:2706–2733. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Azziz R, Carmina E, Chen Z, Dunaif A,
Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ and
Yildiz BO: Polycystic ovary syndrome. Nat Rev Dis Primers.
2:160572016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siddiqui S, Mateen S, Ahmad R and Moin S:
A brief insight into the etiology, genetics, and immunology of
polycystic ovarian syndrome (PCOS). J Assist Reprod Genet.
39:2439–2473. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moghetti P and Tosi F: Insulin resistance
and PCOS: Chicken or egg? J Endocrinol Invest. 44:233–244. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Murri M, Luque-Ramírez M, Insenser M,
Ojeda-Ojeda M and Escobar-Morreale HF: Circulating markers of
oxidative stress and polycystic ovary syndrome (PCOS): A systematic
review and meta-analysis. Hum Reprod Update. 19:268–288. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang XL, Tai H, Xiao XS, Zhang SY, Cui
SC, Qi SB, Hu DD, Zhang LN, Kuang JS, Meng XS and Li SM:
Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of
granulosa cells in rats with polycystic ovarian syndrome. Front
Endocrinol (Lausanne). 13:9621542022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Norman RJ, Dewailly D, Legro RS and Hickey
TE: Polycystic ovary syndrome. Lancet. 370:685–697. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Z, Chen C, Gao Y, Li Y, Zhao X, Zhang
H, Wei Q, Zeng X, Li Y and Wan M: Screening target genes for the
treatment of PCOS via analysis of single-cell sequencing data. Ann
Med. 54:2975–2989. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu X, Sun C, Zou K, Li C, Chen X, Gu H,
Zhou Z, Yang Z, Tu Y, Qin N, et al: Novel PGK1 determines
SKP2-dependent AR stability and reprograms granular cell glucose
metabolism facilitating ovulation dysfunction. EBioMedicine.
61:1030582020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Dong H, Yang L, Yi P, Wang Q and
Huang D: The role of FDX1 in granulosa cell of polycystic ovary
syndrome (PCOS). BMC Endocr Disord. 21:1192021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imanaka-Yoshida K and Aoki H: Tenascin-C
and mechanotransduction in the development and diseases of
cardiovascular system. Front Physiol. 5:2832014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faissner A, Roll L and Theocharidis U:
Tenascin-C in the matrisome of neural stem and progenitor cells.
Mol Cell Neurosci. 81:22–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen S, Fu H, Wu S, Zhu W, Liao J, Hong X,
Miao J, Luo C, Wang Y, Hou FF, et al: Tenascin-C protects against
acute kidney injury by recruiting Wnt ligands. Kidney Int.
95:62–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song W and Qiu N: MiR-495-3p depletion
contributes to myocardial ischemia/reperfusion injury in
cardiomyocytes by targeting TNC. Regen Ther. 21:380–388. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishizaki J, Takemori A, Suemori K,
Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y,
Harigai M, et al: Targeted proteomics reveals promising biomarkers
of disease activity and organ involvement in antineutrophil
cytoplasmic antibody-associated vasculitis. Arthritis Res Ther.
19:2182017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng H, Li L, Xue J, Ma J and Ge J: TNC
accelerates hypoxia-induced cardiac injury in a METTL3-dependent
manner. Genes (Basel). 14:5912023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Chen S, Cui H, Li X, Chen D, Hao W,
Wang J, Li Z, Zheng Z, Zhang Z and Liu H: Tenascin-C-mediated
suppression of extracellular matrix adhesion force promotes
entheseal new bone formation through activation of Hippo signalling
in ankylosing spondylitis. Ann Rheum Dis. 80:891–902. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Imanaka-Yoshida K, Tawara I and Yoshida T:
Tenascin-C in cardiac disease: A sophisticated controller of
inflammation, repair, and fibrosis. Am J Physiol Cell Physiol.
319:C781–C796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dumesic DA, Phan JD, Leung KL, Grogan TR,
Ding X, Li X, Hoyos LR, Abbott DH and Chazenbalk GD: Adipose
insulin resistance in normal-weight women with polycystic ovary
syndrome. J Clin Endocrinol Metab. 104:2171–2183. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu A, Fan Y, Liu S, Sheng L, Sun Y and
Yang H: GIMAP7 induces oxidative stress and apoptosis of ovarian
granulosa cells in polycystic ovary syndrome by inhibiting sonic
hedgehog signalling pathway. J Ovarian Res. 15:1412022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Hu M, Jia W, Liu G, Zhang J, Wang
B, Li J, Cui P, Li X, Lager S, et al: Hyperandrogenism and insulin
resistance modulate gravid uterine and placental ferroptosis in
PCOS-like rats. J Endocrinol. 246:247–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dăneasă A, Cucolaş C, Lenghel LM, Olteanu
D, Orăsan R and Filip GA: Letrozole vs estradiol valerate induced
PCOS in rats: Glycemic, oxidative and inflammatory status
assessment. Reproduction. 151:401–409. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feldmann RE Jr, Maurer MH, Hunzinger C,
Lewicka S, Buergers HF, Kalenka A, Hinkelbein J, Broemme JO,
Seidler GH, Martin E and Plaschke K: Reduction in rat
phosphatidylethanolamine binding protein-1 (PEBP1) after chronic
corticosterone treatment may be paralleled by cognitive impairment:
A first study. Stress. 11:134–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Van Way CW, Dhar A, Reddy R, Evans L,
Wogahn B and Helling TS: Changes in adenine nucleotides during
hemorrhagic shock and reperfusion. J Surg Res. 66:159–166. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weksler B, Schneider A, Ng B and Burt M:
Isolated single lung perfusion in the rat: An experimental model. J
Appl Physiol (1985). 74:2736–2739. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edge D, Shortt CM, Johns EJ, Gobbo OL,
Markos F, Abdulla MH and Barry EF: Assessment of renal function in
the anaesthetised rat following injection of superparamagnetic iron
oxide nanoparticles. Can J Physiol Pharmacol. 95:443–446. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Strohmaier CA, Motloch K, Runge C, Trost
A, Bogner B, Kaser-Eichberger A, Schrödl F, Lenzhofer M and
Reitsamer HA: Retinal vessel diameter responses to central
electrical stimulation in the rat: Effect of nitric oxide synthase
inhibition. Invest Ophthalmol Vis Sci. 57:4553–4557. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clifford PS, Ferguson BS, Jasperse JL and
Hill MA: Arteriolar vasodilation involves actin depolymerization.
Am J Physiol Heart Circ Physiol. 315:H423–H428. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang Y and Zhang X: Luteolin alleviates
polycystic ovary syndrome in rats by resolving insulin resistance
and oxidative stress. Am J Physiol Endocrinol Metab.
320:E1085–E1092. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Corbould A, Kim YB, Youngren JF, Pender C,
Kahn BB, Lee A and Dunaif A: Insulin resistance in the skeletal
muscle of women with PCOS involves intrinsic and acquired defects
in insulin signaling. Am J Physiol Endocrinol Metab.
288:E1047–E1054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
de Medeiros SF, de Medeiros MAS, Santos
NS, Barbosa BB and Yamamoto MMW: Combined oral contraceptive
effects on low-grade chronic inflammatory mediators in women with
polycystic ovary syndrome: A systematic review and meta-analysis.
Int J Inflam. 2018:95915092018.PubMed/NCBI
|
|
33
|
Zheng X, Guo W, Zeng L, Zheng D, Yang S,
Wang L, Wang R, Mol BW, Li R and Qiao J: Live birth after in vitro
maturation versus standard in vitro fertilisation for women with
polycystic ovary syndrome: Protocol for a non-inferiority
randomised clinical trial. BMJ Open. 10:e0353342020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang T, Sha L, Li Y, Zhu L, Wang Z, Li K,
Lu H, Bao T, Guo L, Zhang X and Wang H: Dietary α-linolenic
acid-rich flaxseed oil exerts beneficial effects on polycystic
ovary syndrome through sex steroid hormones-microbiota-inflammation
axis in rats. Front Endocrinol (Lausanne). 11:2842020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Diamanti-Kandarakis E and Dunaif A:
Insulin resistance and the polycystic ovary syndrome revisited: An
update on mechanisms and implications. Endocr Rev. 33:981–1030.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
González F, Considine RV, Abdelhadi OA and
Acton AJ: Oxidative stress in response to saturated fat ingestion
is linked to insulin resistance and hyperandrogenism in polycystic
ovary syndrome. J Clin Endocrinol Metab. 104:5360–5371. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang D, Wang T, Wang R, Zhang X, Wang L,
Xiang Z, Zhuang L, Shen S, Wang H, Gao Q and Wang Y: Suppression of
p66Shc prevents hyperandrogenism-induced ovarian oxidative stress
and fibrosis. J Transl Med. 18:842020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shorakae S, Ranasinha S, Abell S, Lambert
G, Lambert E, de Courten B and Teede H: Inter-related effects of
insulin resistance, hyperandrogenism, sympathetic dysfunction and
chronic inflammation in PCOS. Clin Endocrinol (Oxf). 89:628–633.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu M, Gao J, Zhang Y, Li P, Wang H, Ren X
and Li C: Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic
ovarian syndrome (PCOS) patients in northern China suggest PCOS is
associated with chronic inflammation. Clin Endocrinol (Oxf).
83:913–922. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen H, Yang J and Tan Z: Upregulation of
microRNA-9-5p inhibits apoptosis of chondrocytes through
downregulating Tnc in mice with osteoarthritis following tibial
plateau fracture. J Cell Physiol. 234:23326–23336. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shiba M, Fujimoto M, Imanaka-Yoshida K,
Yoshida T, Taki W and Suzuki H: Tenascin-C causes neuronal
apoptosis after subarachnoid hemorrhage in rats. Transl Stroke Res.
5:238–247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou Y, Ma XY, Han JY, Yang M, Lv C, Shao
Y, Wang YL, Kang JY and Wang QY: Metformin regulates inflammation
and fibrosis in diabetic kidney disease through
TNC/TLR4/NF-κB/miR-155-5p inflammatory loop. World J Diabetes.
12:19–46. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Karataş Z, Baysal T, Sap F, Altın H and
Çiçekler H: The role of tenascin-C and oxidative stress in
rheumatic and congenital heart valve diseases: An observational
study. Anadolu Kardiyol Derg. 13:350–356. 2013.PubMed/NCBI
|
|
44
|
Tong X, Zhang J and Shen M: Silencing of
tenascin-C inhibited inflammation and apoptosis via PI3K/Akt/NF-κB
signaling pathway in subarachnoid hemorrhage cell model. J Stroke
Cerebrovasc Dis. 29:1044852020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Imanaka-Yoshida K: Tenascin-C in heart
diseases-the role of inflammation. Int J Mol Sci. 22:58282021.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yonebayashi S, Tajiri K, Hara M, Saito H,
Suzuki N, Sakai S, Kimura T, Sato A, Sekimoto A, Fujita S, et al:
Generation of transgenic mice that conditionally overexpress
tenascin-C. Front Immunol. 12:6205412021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Patel L, Sun W, Glasson SS, Morris EA,
Flannery CR and Chockalingam PS: Tenascin-C induces inflammatory
mediators and matrix degradation in osteoarthritic cartilage. BMC
Musculoskelet Disord. 12:1642011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chiovaro F, Chiquet-Ehrismann R and
Chiquet M: Transcriptional regulation of tenascin genes. Cell Adh
Migr. 9:34–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Midwood KS, Chiquet M, Tucker RP and Orend
G: Tenascin-C at a glance. J Cell Sci. 129:4321–4327.
2016.PubMed/NCBI
|
|
50
|
Wang Y, He J and Yang J: Eicosapentaenoic
acid improves polycystic ovary syndrome in rats via sterol
regulatory element-binding protein 1 (SREBP-1)/toll-like receptor 4
(TLR4) pathway. Med Sci Monit. 24:2091–2097. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shen HR, Xu X and Li XL: Berberine exerts
a protective effect on rats with polycystic ovary syndrome by
inhibiting the inflammatory response and cell apoptosis. Reprod
Biol Endocrinol. 19:32021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Turner NA: Inflammatory and fibrotic
responses of cardiac fibroblasts to myocardial damage associated
molecular patterns (DAMPs). J Mol Cell Cardiol. 94:189–200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Marzeda AM and Midwood KS: Internal
affairs: Tenascin-C as a clinically relevant, endogenous driver of
innate immunity. J Histochem Cytochem. 66:289–304. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu L, Li YH, Niu YB, Sun Y, Guo ZJ, Li Q,
Li C, Feng J, Cao SS and Mei QB: An apple oligogalactan prevents
against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB
pathway in a mouse model of colitis-associated colon cancer.
Carcinogenesis. 31:1822–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu
J, Cheng W and Yu C: Quercetin decreases insulin resistance in a
polycystic ovary syndrome rat model by improving inflammatory
microenvironment. Reprod Sci. 24:682–690. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bhaskar S, Shalini V and Helen A:
Quercetin regulates oxidized LDL induced inflammatory changes in
human PBMCs by modulating the TLR-NF-κB signaling pathway.
Immunobiology. 216:367–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu M, Zhang Y, Li X, Cui P,
Sferruzzi-Perri AN, Brännström M, Shao LR and Billig H:
TLR4-associated IRF-7 and NFκB signaling act as a molecular link
between androgen and metformin activities and cytokine synthesis in
the PCOS endometrium. J Clin Endocrinol Metab. 106:1022–1040. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jin W, Wang C, Cui M, Wang M, Fu B, Sun L
and Chen X: Inhibitory effect of bushen huoxue formula against
dehydroepiandrosterone-induced inflammation in granulosa cells
through TLR4/NF-κB signaling pathway. Pak J Pharm Sci. 35:701–710.
2022.PubMed/NCBI
|
|
59
|
Yang Y, Yang L, Qi C, Hu G, Wang L, Sun Z
and Ni X: Cryptotanshinone alleviates polycystic ovary syndrome in
rats by regulating the HMGB1/TLR4/NF-κB signaling pathway. Mol Med
Rep. 22:3851–3861. 2020.PubMed/NCBI
|
|
60
|
Ren Y, Ye Y, Xuan F, Chen A, Jin R, Zhou W
and Lu J: The effect of sitagliptin combined with rosiglitazone on
autophagy and inflammation in polycystic ovary syndrome by
regulating PI3K/AKT/mTOR and TLR4/NF-κB pathway. Reprod Biol.
23:1007632023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Midwood K, Sacre S, Piccinini AM, Inglis
J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, et
al: Tenascin-C is an endogenous activator of Toll-like receptor 4
that is essential for maintaining inflammation in arthritic joint
disease. Nat Med. 15:774–780. 2009. View Article : Google Scholar : PubMed/NCBI
|
